Patents by Inventor Mirjam Czjzek

Mirjam Czjzek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides used for treating cancers and, in particular, chronic lymphoid leukaemia
    Patent number: 9745357
    Abstract: The invention relates to the A1 peptide of the sequence RRKYGRDFLLRF, as well as to certain variants thereof, for treating cancers, in particular malignant hematopoietic diseases, and more particularly for treating chronic lymphoid leukaemia.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: August 29, 2017
    Assignees: Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire de Brest, Universite de Bretagne Occidentale, Universite Pierre et Marie Curie (Paris 6)
    Inventors: Bertrand Cosson, Hussam Saad, Patrick Cormier, Christian Berthou, Mirjam Czjzek
  • Bacterial iodoperoxidases from , methods of preparation and uses thereof
    Patent number: 9353354
    Abstract: The present invention concerns iodoperoxidases from Zobellia galactanivorans, isolated nucleic acids encoding same, as well as methods for preparing these enzymes. Moreover, the invention is also directed to the use of such iodoperoxidases in a wide range of industrial, pharmaceutical, medical, cosmetics, and ecological applications, as well as in the food industry.
    Type: Grant
    Filed: July 5, 2012
    Date of Patent: May 31, 2016
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Catherine Leblanc, Ludovic Delage, Gurvan Michel, Etienne Rebuffet, Mirjam Czjzek, Philippe Potin
  • Bacterial Iodoperoxidases from Zobellia Galactanivorans, Methods of Preparation and Uses Thereof
    Publication number: 20140212931
    Abstract: The present invention concerns iodoperoxidases from Zobellia galactanivorans, isolated nucleic acids encoding same, as well as methods for preparing these enzymes. Moreover, the invention is also directed to the use of such iodoperoxidases in a wide range of industrial, pharmaceutical, medical, cosmetics, and ecological applications, as well as in the food industry.
    Type: Application
    Filed: July 5, 2012
    Publication date: July 31, 2014
    Applicants: Universite Pierre et Marie Curie (Paris 6), Centre National de la Recherche Scientifique (CNRS)
    Inventors: Catherine Leblanc, Ludovic Delage, Gurvan Michel, Etienne Rebuffet, Mirjam Czjzek, Philippe Potin
  • Porphyranases, and use thereof for hydrolyzing polysaccharides
    Patent number: 8759039
    Abstract: The present invention relates to the isolation and to the characterization of two proteins having a novel enzymatic activity, i.e. a porphyranase activity. These proteins are useful for hydrolyzing polysaccharides containing sulfated agaro-colloids and for producing oligo-porphyrans, notably oligo-porphyrans with a defined structure and size.
    Type: Grant
    Filed: July 20, 2010
    Date of Patent: June 24, 2014
    Assignee: Centre National de la Recherche Scientifique (C.N.R.S.)
    Inventors: Jan-Hendrik Hehemann, Gaëlle Correc, Gurvan Michel, Tristan Barbeyron, William Helbert, Mirjam Czjzek
  • PORPHYRANASES, AND USE THEREOF FOR HYDROLYZING POLYSACCHARIDES
    Publication number: 20120190836
    Abstract: The present invention relates to the isolation and to the characterization of two proteins having a novel enzymatic activity, i.e. a porphyranase activity. These proteins are useful for hydrolyzing polysaccharides containing sulfated agaro-colloids and for producing oligo-porphyrans, notably oligo-porphyrans with a defined structure and size.
    Type: Application
    Filed: July 20, 2010
    Publication date: July 26, 2012
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S)
    Inventors: Jan-Hendrik Hehemann, Gaëlle Correc, Gurvan Michel, Tristan Barbeyron, William Helbert, Mirjam Czjzek
  • Peptides Used for Treating Cancers and, in Particular, Chronic Lymphoid Leukaemia
    Publication number: 20120172315
    Abstract: The invention relates to the A1 peptide of the sequence RRKYGRDFLLRF, as well as to certain variants thereof, for treating cancers, in particular malignant hematopoietic diseases, and more particularly for treating chronic lymphoid leukaemia.
    Type: Application
    Filed: March 5, 2010
    Publication date: July 5, 2012
    Inventors: Bertrand Cosson, Hussam Saad, Patrick Cormier, Christian Berthou, Mirjam Czjzek